Home
UroGen Pharma URGN paid BGR Government Affairs $30K for lobbying in Q2 2023 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $30,000
- Quarter
- Q2 2023
- Stock
- UroGen Pharma URGN
- Client
- Urogen Pharma
- Reported
- 23/07/20
Up 0.0% from last quarter
What else happened in UroGen Pharma around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Urogen Pharma's other lobbying reports
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 07/20
for Q2
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 04/20
for Q1
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 01/20
for Q4 2025
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 25/10/20
for Q3 2025
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 25/07/21
for Q2 2025